Showing results (91-100 of 313) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2011
Impact of treatment end point definitions on perceived differences in long-term outcome with tyrosine kinase inhibitor therapy in chronic myeloid leukemiaHagop Kantarjian, Susan O'Brien, Elias Jabbour, et al.
Cancer Medicine|December 10, 2014
A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer CenterKhanh Vu, Nhiem V Luong, Julie Hubbard, et al.
Leukemia & Lymphoma|August 3, 2002
Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disordersApostolia M Tsimberidou, Susan M O'Brien, Jorge E Cortes, et al.
Cancer|July 13, 2006
Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemiaStefan Faderl, Kanti Rai, John Gribben, et al.
EMBO Reports|January 10, 2019
The long non-coding RNA LINC00941 and SPRR5 are novel regulators of human epidermal homeostasisChristian Ziegler, Johannes Graf, Stefan Faderl, et al.
Cancer|August 26, 2010
Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission durationHagop M Kantarjian, Deborah Thomas, Farhad Ravandi, et al.
Blood|August 27, 2011
Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centersKiran Naqvi, Elias Jabbour, Carlos Bueso-Ramos, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 18, 2011
Significance of thrombocytopenia in myelodysplastic syndromes: associations and prognostic implicationsAli Al Ameri, Elias Jabbour, Guillermo Garcia-Manero, et al.
Cancer|May 15, 2009
Survival is poorer in patients with secondary core-binding factor acute myelogenous leukemia compared with de novo core-binding factor leukemiaGautam Borthakur, E Lin, Nitin Jain, et al.
Cancer|September 13, 2007
Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failureJorge Cortes, Alfonso Quintás-Cardama, Guillermo Garcia-Manero, et al.
Pageof 32